ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.085

Day Range

$0.083 - $0.087

52 Week Range

$0.065 - $0.125

Volume

0.00

Avg Volume (10D)

1.33M

Market Cap

$102.61M

Price Chart

Market Statistics

Open$0.085

Previous Close$0.085

Day High$0.087

Day Low$0.083

52 Week High$0.125

52 Week Low$0.065

Valuation

Market Cap102.61M

Shares Outstanding1.21B

Price to Book5.46

Trading Activity

Volume0.00

Value Traded0.00

Bid$0.083 × 2,580

Ask$0.085 × 54,419

Performance

1 Day1.18%

5 Day22.86%

13 Week-3.37%

52 Week6.17%

YTD-7.53%

Technical Indicators

RSI (14)60.58

50-Day SMA$0.080

200-Day SMA$0.088

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton